New antibacterial drug approved by FDA to treat complicated urinary tract infections for antimicrobial resistance

Nov 14, 2019: The U.S. Food and Drug Administration (FDA)  approved Shionogi’s Fetroja (cefiderocol), an antibacterial drug used for the patients of 18 years of age or older with complicated urinary tract infections (cUTI), also kidney infections caused by susceptible Gram-negative microorganisms.

Patients known history of severe hypersensitivity to beta-lactam antibacterial drugs are restricted to use this drug. https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-complicated-urinary-tract-infections-part-ongoing-efforts